Literature DB >> 6702864

Effects of prazosin and propranolol on serum lipids in patients with essential hypertension.

J Lowenstein, A J Neusy.   

Abstract

The effects of prazosin and propranolol on total serum cholesterol concentration, low-density lipoprotein and high-density lipoprotein cholesterol fractions, and serum triglyceride concentration were compared in a crossover study in 29 patients with mild to moderate essential hypertension. All patients received polythiazide at a constant dose throughout control and drug treatment periods. Comparable blood pressure reduction was achieved with prazosin (9.3 +/- 7.1 mg per day) and propranolol (183.6 +/- 154.5 mg per day). Prazosin administration was associated with a significant reduction in the concentrations of total serum cholesterol (-5.5 percent), triglyceride (-20.0 percent), and low-density lipoprotein cholesterol (-10.1 percent). High-density lipoprotein cholesterol concentration increased (+8.0 percent) as did the ratio high-density lipoprotein: total cholesterol (+14.1 percent). No significant changes in any of the serum lipid fractions were observed during propranolol administration.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6702864     DOI: 10.1016/0002-9343(84)90960-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

Review 1.  Selective alpha 1-adrenoreceptor blockers in the treatment of hypertension: should we be using them more?

Authors:  M Ligueros; R Unwin; M Wilkins
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

Review 2.  The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs.

Authors:  R P Ames
Journal:  Drugs       Date:  1986-10       Impact factor: 9.546

Review 3.  The effects of diuretics and adrenergic-blocking agents on plasma lipids.

Authors:  J J Rohlfing; J D Brunzell
Journal:  West J Med       Date:  1986-08

4.  Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension.

Authors:  T Pollare; H Lithell; I Selinus; C Berne
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

Review 5.  Insulin resistance syndrome: possible key role of blood flow in resting muscle.

Authors:  P O Ganrot
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

Review 6.  Serum lipoproteins during treatment with antihypertensive drugs.

Authors:  P Weidmann; C Ferrier; H Saxenhofer; D E Uehlinger; B N Trost
Journal:  Drugs       Date:  1988       Impact factor: 9.546

7.  The effect of celiprolol on the blood lipid profile in hypertensive patients with high cholesterol levels.

Authors:  R Fogari; A Zoppi; F Tettamanti; G Malamani; C Pasotti
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

8.  Coronary risk factors in maintenance hemodialysis patients: Who is the culprit - hemodialysis or chronic renal failure?

Authors:  Kapil Gupta; Rajiv Mahajan
Journal:  Int J Appl Basic Med Res       Date:  2011-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.